{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal XCEL-MT-OSTEO-ALPHA",
            "NStudiesAvail": 430108,
            "NStudiesFound": 3,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 3,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "The present study evaluates the effect of XCEL-MT-OSTEO-ALPHA in non-union fractures (pseudoarthrosis) of long bones in comparison to the standard treatment of autologous iliac crest.\n\nXCEL-MT-OSTEO-ALPHA is a tissue engineering product composed by \"ex-vivo\" expanded autologous mesenchymal stromal cells fixed in allogenic bone tissue, produced by Xcelia (Blood and Tissue Bank of Catalonia).\n\nThe working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration up to consolidation of non-union fractures."
                        ],
                        "BriefTitle": [
                              "Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "UNKNOWN"
                        ],
                        "CollaboratorName": [
                              "Hospital ASEPEYO Sant Cugat"
                        ],
                        "CompletionDate": [
                              "December 20, 2019"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Atrophic Nonunion of Fracture"
                        ],
                        "ConditionAncestorId": [
                              "D000014947"
                        ],
                        "ConditionAncestorTerm": [
                              "Wounds and Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All",
                              "BC23"
                        ],
                        "NCTId": [
                              "NCT02230514"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "The present study evaluates the effect of XCEL-MT-OSTEO-ALPHA in osteonecrosis of the femoral head in comparison to the standard treatment of isolated core decompression.\n\nXCEL-MT-OSTEO-ALPHA is a tissue engineering product composed by \"ex-vivo\" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue.\n\nThe working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration, avoiding the progression to collapse of the femoral head."
                        ],
                        "BriefTitle": [
                              "Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "OTHER_GOV",
                              "OTHER_GOV",
                              "OTHER"
                        ],
                        "CollaboratorName": [
                              "Ministerio de Sanidad, Servicios Sociales e Igualdad",
                              "Ministerio de Ciencia e Innovaci\u00f3n, Spain",
                              "European Regional Development Fund"
                        ],
                        "CompletionDate": [
                              "June 27, 2019"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Avascular Necrosis of Femur Head"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000001847",
                              "D000009140"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Bone Diseases",
                              "Musculoskeletal Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All",
                              "BC05",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT01605383"
                        ]
                  },
                  {
                        "Rank": 3,
                        "BriefSummary": [
                              "The present prospective, randomized study, compares the spinal fusion obtained after instrumentation and the use of a biologic product (patient's mesenchymal cells obtained from his/her own bone marrow which will be fixed in human bone tissue form a donor), with the current procedure that consists in instrumented spinal fusion and the use of each patient's bone obtained from his/her iliac crest.\n\nThe working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration, avoiding the need for obtaining patient's iliac crest and its associated morbidity."
                        ],
                        "BriefTitle": [
                              "Safety Study of Mesenchymal Stem Cells and Spinal Fusion"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "INDUSTRY",
                              "OTHER_GOV",
                              "OTHER_GOV"
                        ],
                        "CollaboratorName": [
                              "TFS Trial Form Support",
                              "Ministerio de Sanidad, Servicios Sociales e Igualdad",
                              "Ministerio de Ciencia e Innovaci\u00f3n, Spain"
                        ],
                        "CompletionDate": [
                              "October 21, 2019"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Lumbar Spondylolisthesis Involving L4-L5, and/or",
                              "Degenerative Discopathy Involving L4-L5"
                        ],
                        "ConditionAncestorId": [
                              "D000013169",
                              "D000055009",
                              "D000013122",
                              "D000001847",
                              "D000009140"
                        ],
                        "ConditionAncestorTerm": [
                              "Spondylolysis",
                              "Spondylosis",
                              "Spinal Diseases",
                              "Bone Diseases",
                              "Musculoskeletal Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC05",
                              "All"
                        ],
                        "NCTId": [
                              "NCT01552707"
                        ]
                  }
            ]
      }
}